Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2003
08/07/2003US20030147916 Recombinant influenza a viruses
08/07/2003US20030147915 Antibodies specific for seroreactive regions on HPV 16 proteins E1 and E2
08/07/2003US20030147914 Inactivated, whole or partial Mycoplasma bovis cell and a pharmaceutically acceptable carrier; for cattle
08/07/2003US20030147903 ABC transport polynucleotides, polypeptides and antibodies
08/07/2003US20030147902 Method of stimulating and immune response by administration of host organisms that express intimin alone of as a fusion protein with one of more other antigens
08/07/2003US20030147883 Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infection
08/07/2003US20030147856 Proteins
08/07/2003US20030147850 Composition and methods for potentiating therapeutic effects of interferons
08/07/2003CA2849427A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
08/07/2003CA2714295A1 Desaturase genes, enzymes encoded thereby, and uses thereof
08/07/2003CA2475003A1 Double-stranded oligonucleotides
08/07/2003CA2474910A1 Oligonucleotide compositions with enhanced efficiency
08/07/2003CA2474852A1 Use of pde5 inhibitors in the treatment of scarring and fibrosis
08/07/2003CA2474850A1 Imidazo[1,2-a]pyridine derivatives
08/07/2003CA2474821A1 Anti-viral compounds
08/07/2003CA2474809A1 Dry granulated formulations of azithromycin
08/07/2003CA2474794A1 Method of providing prophylaxis for tuberculosis in hiv positive individuals
08/07/2003CA2474718A1 Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterial, related compositions and methods
08/07/2003CA2474702A1 Heterocyclic arylsulfonamidobenzylic compounds
08/07/2003CA2474649A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003CA2474567A1 Amidases, nucleic acids encoding them and methods for making and using them
08/07/2003CA2474497A1 Compositions and methods related to tim-3, a th1-specific cell surface molecule
08/07/2003CA2474456A1 5-ring heterocycles used as antiviral agents
08/07/2003CA2474434A1 Condensed heterocyclic compounds
08/07/2003CA2474414A1 Oligonucleotides comprising alternating segments and uses thereof
08/07/2003CA2473457A1 Cotherapy with an oxazolidinone and a vitamin b
08/07/2003CA2473164A1 Novel compounds that inhibit factor xa activity
08/07/2003CA2471934A1 Crystalline hydrochloride of 7-(((5-amino-1,2,4-thiadiazol-3-yl)(fluoromethoxyimino)acetyl)amino)-3-((imino-1-piperazinylmethyl)methylhydrazono)-methyl-3-cephem-4-carboxylic acid
08/07/2003CA2469738A1 Expression vectors encoding epitopes of target-associated antigens and methods for their design
08/07/2003CA2469571A1 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
08/07/2003CA2466228A1 Method for treating diseases with omega interferon
08/07/2003CA2466025A1 Rsv proteins, antibodies, compositions, methods and uses
08/07/2003CA2465265A1 Degp protease: cleavage site identification and proteolysis of a natural target in e. coli
08/07/2003CA2464869A1 Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases
08/07/2003CA2464138A1 Methods of preventing and treating flavivirus infection in animals
08/07/2003CA2463476A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
08/06/2003EP1333025A1 Cyanopyrrolidine derivatives
08/06/2003EP1332675A2 Synergistic microbicidal combinations
08/06/2003EP1332372A2 Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression
08/06/2003EP1332231A2 Methods for measuring drug resistance
08/06/2003EP1332209A2 Collections of repeat proteins comprising repeat modules
08/06/2003EP1332159A1 Process for the preparation of latent antithrombin iii
08/06/2003EP1332157A2 Prokineticin polypeptides, related compositions and methods
08/06/2003EP1332155A2 Immunization of dairy cattle with gapc protein against streptococcus infection
08/06/2003EP1332154A1 Novel therapeutic compositions for treating infection by lawsonia spp
08/06/2003EP1332149A1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase
08/06/2003EP1332146A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/06/2003EP1332145A1 Process for formulation of antibiotic compounds
08/06/2003EP1332136A2 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/06/2003EP1332134A2 Inhibitors of prenyl-protein transferase
08/06/2003EP1332131A2 Acid derivatives useful as serine protease inhibitors
08/06/2003EP1331947A2 Use of citric acid as antimicrobial agent or enhancer or as anticancer agent
08/06/2003EP1331946A2 Synergistic medicament containing aromatic agents and having an antagonistic, regenerative and/or protagonist decontamination effect
08/06/2003EP1331945A2 Otic microbial combinations for treatment of animals with ruptured tympanic membrane
08/06/2003EP1331943A2 Nucleic acid molecules and polypeptides for immune modulation
08/06/2003EP1331932A2 Therapeutic uses for ip 3? receptor-mediated calcium channel modulators
08/06/2003EP1207865B1 Composition for treatment of infections of humans and animals
08/06/2003EP1165544B1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
08/06/2003EP1162945B1 Particle based vaccine composition
08/06/2003EP1140152B1 Method to produce inactivated w/o emulsion adjuvated vaccines
08/06/2003EP1117648B1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors
08/06/2003EP1109811B1 Pyrrolobenzodiazepines
08/06/2003EP1077684B1 Effervescent preparations
08/06/2003EP1030734B1 Encapsulate of active material in alginate matrix
08/06/2003EP0994890B1 Benzimidazole derivatives
08/06/2003EP0985052B1 Methods and compositions to identify swine genetically resistant to f18 e. coli associated diseases
08/06/2003EP0973499B1 Diffusional implantable delivery system
08/06/2003EP0824350B1 Use of an antifungal composition
08/06/2003EP0695305B1 Method of forming oligonucleotides
08/06/2003EP0687182B1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
08/06/2003CN1434864A Method of enhancing immune responses to herpes simplex virus vaccine
08/06/2003CN1434831A Improvments in or relating to immune responses to HIV
08/06/2003CN1434830A 2-aminocarbonyl-9H-punine derivatives
08/06/2003CN1434829A Processes for preparing clarithromycin polymorphs and novel polymorph IV
08/06/2003CN1434827A 新的哌啶和哌嗪衍生物 The new piperidine and piperazine derivatives
08/06/2003CN1434823A 3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434820A Cyclic AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434818A Novel compounds
08/06/2003CN1434817A Pyrazole cyclic AMP-specific PDE inhibitors
08/06/2003CN1434813A Pyrrolidine derivatives cyclic AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434812A Thizaolyl amide derivatives
08/06/2003CN1434810A Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidiones as antibacterials
08/06/2003CN1434805A 选择性神经激肽拮抗剂 Selective neurokinin antagonists
08/06/2003CN1434799A Cyclic amp-specific phosphodiesterase inhibitors
08/06/2003CN1434798A Pyrrolidines which inhibit CAMP-specific PDE
08/06/2003CN1434797A Hydrazone and oxime derivatives of pyrrolidine as AMP-specific phosphodiesterase inhibitons
08/06/2003CN1434796A Acylphenylurea derivatives, a process for their preparation and their use as pharmaceuticals
08/06/2003CN1434795A Acyl pseudodipeptides which carry a functionalised auxiliary arm
08/06/2003CN1434718A Activation and inhibition of immune system
08/06/2003CN1434716A Anti-adhesive agent in relation to pathogenic flora of skin
08/06/2003CN1434712A Nitrosated and nitrosylated cyclooxygenase-2 inhibitors compositions and methods of use
08/06/2003CN1434711A Use of substances that act as cascade inhibitors of the Raf/MEK/ERK signal cascade, for producing a medicament to treat dna and rna viruses
08/06/2003CN1434710A Specific therapeutic composition for treating AIDS
08/06/2003CN1434705A Use of hydroxide-releasing agents as skin permeation enhancers
08/06/2003CN1434704A System and method for extended delivery of therapeutic agent with its receptor loading dose
08/06/2003CN1434121A Fermentation production technology for olry bacterial powder containing gama-linolenic acid
08/06/2003CN1434052A Cranesbill total flavonoid extract and use in preparation of anti-virus medicine
08/06/2003CN1433812A Duplication double localization type intracellular vaccine
08/06/2003CN1433811A Use of bifidobacterium cell wall and bifidobacterium cell wall protein in pharmacy
08/06/2003CN1433804A Medicine for treating wind-heat syndrome due to exopathy and preparation process thereof
1 ... 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 ... 1798